The synthesis and study of profiles of the ornidazole impurities
Journal Title: ScienceRise: Pharmaceutical Science - Year 2018, Vol 0, Issue 1
Abstract
<p>Pharmacopoeial reference standards (PhRSs) provide the comparability of the test results of generic drugs. PhRSs of ornidazole impurities are not described in pharmacopoeias. Therefore, the establishment of PhRSs of the State Pharmacopeia of Ukraine (SPhU RSs) of ornidazole impurities is an essential task, the integral part of which is synthesis and characterisation of ornidazole impurities.</p><p><strong>Aim:</strong> To synthesise impurities of ornidazole as candidate materials for certification as SPhU RSs and study their profiles in the substance and infusion solution of ornidazole.</p><p><strong>Methods:</strong> Traditional methods of organic synthesis, <sup>1</sup>Н NMR spectroscopy, IR absorption spectrophotometry, the capillary method for the melting point determination, liquid chromatography with a spectrophotometric detector. <strong></strong></p><p><strong>Results: </strong>Ornidazole-diol and ornidazole-epoxide were synthesized, and their structures were confirmed using <sup>1</sup>Н NMR and IR spectra. Their chromatographic profiles in the substance and the infusion drug of ornidazole being under pharmaceutical development were studied. The problem with the ornidazole-diol determination by the manufacturer’s procedure was found, and its correction was proposed. The purity of the compounds synthesized was approximately 99.5 %. In the substance, the content of ornidazole-epoxide exceeded 0.1 %, whereas the content of ornidazole-diol was negligible. In the drug, the content of ornidazole-epoxide reduced to zero with time, while the content of ornidazole-diol increased considerably (to approx. 3 %).</p><p><strong>Conclusions:</strong> The efficient methods for the synthesis of ornidazole-epoxide and ornidazole-diol were developed, and the synthesis was conducted. The profiles of the synthesized impurities in the substance and the infusion drug of ornidazole being under pharmaceutical development were studied. It was found that ornidazole-epoxide and ornidazole-diol are present in the substance and the drug at the level which requires their identification and quantitative determination. The proposed methods for synthesis provide obtaining ornidazole-diol and ornidazole-epoxide of high purity, which enables to use them as the candidate materials for certification as SPhU RSs</p>
Authors and Affiliations
Dmytro Leontiev, Olena Bevz, Natalia Volovyk, Ivan Gella, Victoria Georgiyants
Keywords
Related Articles
- EP ID EP526806
- DOI 10.15587/2519-4852.2018.123387
- Views 265
- Downloads 0
Prediction of the competitiveness dynamics of pharmacy chains
<p>In market economy, one of the main tasks of any enterprise (organization) is to defeat rival competitors. It should not be single or random victory, but it should be natural result of effective management of this proc...
New possibilities of use of oat raw materials for investigation of biologically active components in therapy of experimental diabetes
<p>Aim of the work is to suggest the technology of aqua dynamic extraction of bioactive substances from oat straw. The amount of the extract and the concentration of extracted substances depend on the duration of extract...
Synthesis of potential antiexudative preparations for 2-((4-amino-5-(furan-2-il)-1,2,4-triazole-(4H)-3-yl)-sulfanyl)-N-acetamide series
<p><strong>Aim.</strong> Conduct the purposeful synthesis of new potential biologically active substances of derivatives of 2 - ((4-amino-5- (furan-2-yl) -1,2,4-triazol (4H) -3-yl) -sulfanyl) -N-acetamides and evaluate t...
Scientific substantiation of the product range renewal model for manufacturing pharmaceutical enterprise
<p>In modern conditions, aggravation of competition in the national pharmaceutical market, increase in cost of scientific developments and investments in pharmaceutical industry, raising of the level of requirements and...
Development of composition and technology of combination drug with neurally mediated action «Memofit»
<p> </p><p><strong>Aim. </strong>The aim of this work is to<strong> </strong>develop composition of combination drug in the form of hard-gelatin capsules «Memofit», determine technological and microbiological parameters...